Provided by Tiger Trade Technology Pte. Ltd.

Arbutus Biopharma

4.54
-0.1000-2.16%
Post-market: 4.540.00000.00%19:55 EST
Volume:831.49K
Turnover:3.79M
Market Cap:873.15M
PE:-20.21
High:4.70
Open:4.65
Low:4.51
Close:4.64
52wk High:5.10
52wk Low:2.71
Shares:192.32M
Float Shares:126.05M
Volume Ratio:0.50
T/O Rate:0.66%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2246
EPS(LYR):-0.3767
ROE:-45.88%
ROA:-16.46%
PB:11.28
PE(LYR):-12.05

Loading ...

Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 28, 2024

Major Issues Report

Form 8-K - Current report
May 22, 2024

Major Issues Report

Form 8-K - Current report
May 17, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 09, 2024

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 02, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
May 02, 2024

Major Issues Report

Form 8-K - Current report
Apr 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 04, 2024

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 10, 2023

Major Issues Report

Form 8-K - Current report
Nov 07, 2023

Major Issues Report

Form 8-K - Current report